{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:57:06Z","timestamp":1793048226505,"version":"4.5.0"},"reference-count":274,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.pharmthera.2019.02.015","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T12:04:28Z","timestamp":1551182668000},"page":"135-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":156,"special_numbering":"C","title":["CD26\/DPP4 - a potential biomarker and target for cancer therapy"],"prefix":"10.1016","volume":"198","author":[{"given":"Njanja","family":"Enz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendolyn","family":"Vliegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"De Meester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Jungraithmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.pharmthera.2019.02.015_bb0005","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1046\/j.1432-1327.2000.01617.x","article-title":"Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8","volume":"267","author":"Abbott","year":"2000","journal-title":"European Journal of Biochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000024497","article-title":"Truncated dipeptidyl peptidase IV is a potent anti-adhesion and anti-metastasis peptide for rat breast cancer cells","volume":"18","author":"Abdel-Ghany","year":"1998","journal-title":"Invasion and Metastasis"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2407-11-51","article-title":"Mechanisms of confluence-dependent expression of CD26 in colon cancer cell lines","volume":"11","author":"Abe","year":"2011","journal-title":"BMC Cancer"},{"issue":"15","key":"10.1016\/j.pharmthera.2019.02.015_bb0020","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1158\/0008-5472.CAN-04-0447","article-title":"PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism","volume":"64","author":"Adams","year":"2004","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbaexp.2004.03.010","article-title":"Dipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DPIV-like peptidase activity","volume":"1679","author":"Ajami","year":"2004","journal-title":"Biochimica et Biophysica Acta"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb0030","first-page":"1369","article-title":"Overexpression of CD26\/DPPIV in mesothelioma tissue and mesothelioma cell lines","volume":"26","author":"Amatya","year":"2011","journal-title":"Oncology Reports"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0035","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pharmthera.2016.07.009","article-title":"Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: Potential impact of dipeptidyl peptidase-4 inhibitors","volume":"167","author":"Anderluh","year":"2016","journal-title":"Pharmacology & Therapeutics"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.02.015_bb0040","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/bjc.2017.62","article-title":"First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers","volume":"116","author":"Angevin","year":"2017","journal-title":"British Journal of Cancer"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.02.015_bb0045","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-11-1990","article-title":"CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma","volume":"18","author":"Aoe","year":"2012","journal-title":"Clinical Cancer Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/10799893.2013.828072","article-title":"Study of the interaction among Notch pathway receptors, correlation with stemness, as well as their interaction with CD44, dipeptidyl peptidase-IV, hepatocyte growth factor receptor and the SETMAR transferase, in colon cancer stem cells","volume":"33","author":"Apostolou","year":"2013","journal-title":"Journal of Receptors and Signal Transduction"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb0055","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/ajcp\/96.3.306","article-title":"Dipeptidyl aminopeptidase IV staining of cytologic preparations to distinguish benign from malignant thyroid diseases","volume":"96","author":"Aratake","year":"1991","journal-title":"American Journal of Clinical Pathology"},{"issue":"19","key":"10.1016\/j.pharmthera.2019.02.015_bb0060","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1158\/0008-5472.CAN-13-0926","article-title":"Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis","volume":"73","author":"Arendt","year":"2013","journal-title":"Cancer Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.02.015_bb0065","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/onc.2011.298","article-title":"Upregulation of CD26 expression in epithelial cells and stromal cells during wound-induced skin tumour formation","volume":"31","author":"Arwert","year":"2012","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb0070","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.3892\/or.2014.3162","article-title":"Upregulated expression and activation of membrane-associated proteases in esophageal squamous cell carcinoma","volume":"31","author":"Augoff","year":"2014","journal-title":"Oncology Reports"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1155\/2004\/834309","article-title":"Clinical interest of the combined use of serum CD26 and alpha-L-fucosidase in the early detection diagnosis of colorectal cancer","volume":"19","author":"Ayude","year":"2004","journal-title":"Disease Markers"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0080","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/s41467-017-01867-9","article-title":"Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence","volume":"8","author":"Bailey","year":"2017","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/dbio.2001.0399","article-title":"Activins as regulators of branching morphogenesis","volume":"238","author":"Ball","year":"2001","journal-title":"Developmental Biology"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.02.015_bb0090","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/ni.3201","article-title":"Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy","volume":"16","author":"Barreira da Silva","year":"2015","journal-title":"Nature Immunology"},{"issue":"7\u20138","key":"10.1016\/j.pharmthera.2019.02.015_bb0095","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/sj.bjc.6690167","article-title":"Constitutive expression of CD26\/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia","volume":"79","author":"Bauvois","year":"1999","journal-title":"British Journal of Cancer"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.02.015_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134305","article-title":"Differential expression and enzymatic activity of DPPIV\/CD26 affects migration ability of cervical carcinoma cells","volume":"10","author":"Beckenkamp","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2133.2001.04014.x","article-title":"The relevance of the CD4+ CD26- subset in the identification of circulating S\u00e9zary cells","volume":"144","author":"Bernengo","year":"2001","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.02.015_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127318","article-title":"Serum calprotectin, CD26 and EGF to establish a panel for the diagnosis of lung cancer","volume":"10","author":"Blanco-Prieto","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb0115","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.neo.2018.04.004","article-title":"Phenotyping and target expression profiling of CD34+\/CD38\u2212and CD34+\/CD38+stem- and progenitor cells in acute lymphoblastic leukemia","volume":"20","author":"Blatt","year":"2018","journal-title":"Neoplasia"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.02.015_bb0120","first-page":"1499","article-title":"Metastatic dormancy: a complex network between cancer stem cells and their microenvironment","volume":"29","author":"Bleau","year":"2014","journal-title":"Histology and Histopathology"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0125","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1186\/s12885-015-1757-0","article-title":"Serum CD26 levels in patients with gastric cancer: a novel potential diagnostic marker","volume":"15","author":"Boccardi","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fonc.2018.00194","article-title":"Residual peripheral blood cd26+ leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission","volume":"8","author":"Bocchia","year":"2018","journal-title":"Frontiers in Oncology"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb0135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/(SICI)1097-0045(19971201)33:4<225::AID-PROS1>3.0.CO;2-G","article-title":"Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue","volume":"33","author":"Bogenrieder","year":"1997","journal-title":"The Prostate"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.02.015_bb0140","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.metabol.2014.04.002","article-title":"Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a Mouse model of Western diet induced obesity","volume":"63","author":"Bostick","year":"2014","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00428-018-2487-x","article-title":"Expression and clinical role of the dipeptidyl peptidases DPP8 and DPP9 in ovarian carcinoma","volume":"474","author":"Brunetti","year":"2019","journal-title":"Virchows Archiv"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb0150","doi-asserted-by":"crossref","first-page":"443","DOI":"10.33549\/physiolres.931231","article-title":"Modulation of substance P signaling by dipeptidyl peptidase-IV enzymatic activity in human glioma cell lines","volume":"57","author":"Busek","year":"2008","journal-title":"Physiological Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.02.015_bb0155","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.biocel.2012.01.011","article-title":"Dipeptidyl peptidase-IV inhibits glioma cell growth independent of its enzymatic activity","volume":"44","author":"Busek","year":"2012","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.02.015_bb0160","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.pan.2016.06.001","article-title":"Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma","volume":"16","author":"Busek","year":"2016","journal-title":"Pancreatology"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.02.015_bb0165","first-page":"1223","article-title":"The ectopeptidases CD10, CD13, CD26, and CD143 are upregulated in gastric cancer","volume":"25","author":"Carl-McGrath","year":"2004","journal-title":"International Journal of Oncology"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.02.015_bb0170","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopha.2009.02.001","article-title":"A 57-gene expression signature in B-cell chronic lymphocytic leukemia","volume":"63","author":"Carlucci","year":"2009","journal-title":"Biomedicine and Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb0175","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/cei.13163","article-title":"Lymphocytes are a major source of circulating soluble dipeptidyl peptidase 4","volume":"194","author":"Casrouge","year":"2018","journal-title":"Clinical and Experimental Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0180","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13046-018-0869-1","article-title":"Downregulating CD26\/DPPIV by apigenin modulates the interplay between Akt and Snail\/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses","volume":"37","author":"Chang","year":"2018","journal-title":"Journal of Experimental & Clinical Cancer Research: CR"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb0185","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s13300-016-0198-3","article-title":"Incretin-based therapy and risk of pancreatic cancer in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials","volume":"7","author":"Chen","year":"2016","journal-title":"Diabetes Therapy"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.02.015_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3056","article-title":"Targeting dipeptidyl peptidase 8 genes inhibits proliferation, migration and invasion by inhibition of Cyclin D1 and MMP2MMP9 signal pathway in cervical cancer","volume":"20","author":"Chen","year":"2018","journal-title":"The Journal of Gene Medicine"},{"issue":"37","key":"10.1016\/j.pharmthera.2019.02.015_bb0195","doi-asserted-by":"crossref","first-page":"24207","DOI":"10.1074\/jbc.273.37.24207","article-title":"Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin","volume":"273","author":"Cheng","year":"1998","journal-title":"The Journal of Biological Chemistry"},{"issue":"27","key":"10.1016\/j.pharmthera.2019.02.015_bb0200","doi-asserted-by":"crossref","first-page":"24600","DOI":"10.1074\/jbc.M303424200","article-title":"A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis","volume":"278","author":"Cheng","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.02.015_bb0205","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1023\/A:1006757525190","article-title":"Is the Fischer 344\/CRJ rat a protein-knock-out model for dipeptidyl peptidase IV-mediated lung metastasis of breast cancer?","volume":"17","author":"Cheng","year":"1999","journal-title":"Clinical & Experimental Metastasis"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb0210","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3390\/ijms18061106","article-title":"Emergence of CD26+ Cancer Stem Cells with Metastatic Properties in Colorectal Carcinogenesis","volume":"18","author":"Cheung","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"issue":"21","key":"10.1016\/j.pharmthera.2019.02.015_bb0215","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1111\/bph.13274","article-title":"Dipeptidyl peptidase 4 promotes epithelial cell transformation and breast tumourigenesis via induction of PIN1 gene expression","volume":"172","author":"Choi","year":"2015","journal-title":"British Journal of Pharmacology"},{"issue":"19","key":"10.1016\/j.pharmthera.2019.02.015_bb0220","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.3748\/wjg.v19.i19.2883","article-title":"Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver","volume":"19","author":"Chowdhury","year":"2013","journal-title":"World Journal of Gastroenterology"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.02.015_bb0225","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1054\/bjoc.2000.1410","article-title":"Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer","volume":"83","author":"Cordero","year":"2000","journal-title":"British Journal of Cancer"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb0230","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5306\/wjco.v2.i6.245","article-title":"Potential of soluble CD26 as a serum marker for colorectal cancer detection","volume":"2","author":"Cordero","year":"2011","journal-title":"World Journal of Clinical Oncology"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.02.015_bb0235","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00262-009-0728-1","article-title":"On the origin of serum CD26 and its altered concentration in cancer patients","volume":"58","author":"Cordero","year":"2009","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb0240","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/hon.888","article-title":"CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL","volume":"27","author":"Cro","year":"2009","journal-title":"Hematological Oncology"},{"issue":"22","key":"10.1016\/j.pharmthera.2019.02.015_bb0245","doi-asserted-by":"crossref","first-page":"33016","DOI":"10.18632\/oncotarget.9108","article-title":"Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: Patient-subgroups, prognostic impact, and technical aspects","volume":"7","author":"Culen","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.02.015_bb0250","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1016\/S0021-9258(18)42906-7","article-title":"Dipeptidyl peptidase IV (CD 26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. Cloning of the complete human coding sequence and changes of dipeptidyl peptidase IV mRNA levels during cell differentiation","volume":"267","author":"Darmoul","year":"1992","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb0255","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1080\/14756360802334800","article-title":"CD26\/DPPIV cell membrane expression and DPPIV activity in plasma of patients with acute leukemia","volume":"24","author":"De Andrade","year":"2009","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.02.015_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107470","article-title":"Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients","volume":"9","author":"De Chiara","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0265","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/1471-2407-10-333","article-title":"Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas","volume":"10","author":"De Chiara","year":"2010","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb0270","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/eji.1830240311","article-title":"Binding of adenosine deaminase to the lymphocyte surface via CD26","volume":"24","author":"De Meester","year":"1994","journal-title":"European Journal of Immunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb0275","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/sj.bjc.6604194","article-title":"Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: Comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV","volume":"98","author":"De Micco","year":"2008","journal-title":"British Journal of Cancer"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb0280","doi-asserted-by":"crossref","first-page":"679","DOI":"10.15252\/emmm.201506145","article-title":"Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post-translational modification: prospective placebo-controlled clinical studies","volume":"8","author":"Decalf","year":"2016","journal-title":"EMBO Molecular Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb0285","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.tice.2011.11.003","article-title":"Comparison of the activity levels and localization of dipeptidyl peptidase IV in normal and tumor human lung cells","volume":"44","author":"Dimitrova","year":"2012","journal-title":"Tissue & Cell"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb0290","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/path.1711600303","article-title":"Adenosine deaminase complexing protein (ADCP) expression and metastatic potential in prostatic adenocarcinomas","volume":"160","author":"Dinjens","year":"1990","journal-title":"The Journal of Pathology"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb0295","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2559.2009.03399.x","article-title":"Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours","volume":"55","author":"Dohi","year":"2009","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb0300","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/cyto.a.23300","article-title":"Antibody-based cell-surface proteome profiling of metastatic breast cancer primary explants and cell lines","volume":"93","author":"Donnenberg","year":"2018","journal-title":"Cytometry Part A"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0305","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pathophys.2006.09.003","article-title":"CD26\/DPPIV expression and 8-azaguanine response in T-acute lymphoblastic leukaemia cell lines in culture","volume":"14","author":"Dourado","year":"2007","journal-title":"Pathophysiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2017.11.006","article-title":"Inhibition of endosteal vascular niche remodeling rescues hematopoietic stem cell loss in AML","volume":"22","author":"Duarte","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb0315","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1369\/jhc.2009.952739","article-title":"Enzyme activity and immunohistochemical localization of dipeptidyl peptidase 8 and 9 in male reproductive tissues","volume":"57","author":"Dubois","year":"2009","journal-title":"The Journal of Histochemistry and Cytochemistry"},{"issue":"28","key":"10.1016\/j.pharmthera.2019.02.015_bb0320","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.3748\/wjg.v23.i28.5127","article-title":"Involvement of CRF2 signaling in enterocyte differentiation","volume":"23","author":"Ducarouge","year":"2017","journal-title":"World Journal of Gastroenterology"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.02.015_bb0325","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/CJI.0b013e3182a80213","article-title":"A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapy","volume":"36","author":"Duncan","year":"2013","journal-title":"Journal of Immunotherapy"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0330","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1186\/s12885-018-4758-y","article-title":"ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells","volume":"18","author":"Durinikova","year":"2018","journal-title":"BMC Cancer"},{"issue":"17","key":"10.1016\/j.pharmthera.2019.02.015_bb0335","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1046\/j.1432-1327.2000.01634.x","article-title":"Molecular characterization of dipeptidyl peptidase activity in serum soluble CD26\/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides","volume":"267","author":"Durinx","year":"2000","journal-title":"European Journal of Biochemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb0340","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.clon.2009.04.007","article-title":"Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer","volume":"21","author":"Eager","year":"2009","journal-title":"Clinical Oncology"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0345","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1471-2407-9-263","article-title":"Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma","volume":"9","author":"Eager","year":"2009","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb0350","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.3892\/ijo.2016.3725","article-title":"Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells","volume":"49","author":"El Khoury","year":"2016","journal-title":"International Journal of Oncology"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0355","series-title":"Galvus: European Public Assessment Report - Scientific Discussion","author":"EMA","year":"2007"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.02.015_bb0360","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.imbio.2011.01.005","article-title":"Serum DPPIV activity and CD26 expression on lymphocytes in patients with benign or malignant breast tumors","volume":"216","author":"Eri\u0107-Nikoli\u0107","year":"2011","journal-title":"Immunobiology"},{"issue":"March","key":"10.1016\/j.pharmthera.2019.02.015_bb0365","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.lfs.2018.03.014","article-title":"SerpinB3 induces dipeptidyl-peptidase IV\/CD26 expression and its metabolic effects in hepatocellular carcinoma","volume":"200","author":"Fasolato","year":"2018","journal-title":"Life Sciences"},{"issue":"02","key":"10.1016\/j.pharmthera.2019.02.015_bb0370","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1055\/s-2008-1033874","article-title":"Zytochemische Darstellung der Blasten bei akuter T-lymphoblastischer Leuk\u00e4mie mit Hilfe der Glycyl-prolyl-4-methoxy-beta-naphthylamid-Peptidase (DAP IV)","volume":"192","author":"Feller","year":"1980","journal-title":"Klinische P\u00e4diatrie"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.02.015_bb0375","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1002\/ijc.28260","article-title":"Long-term treatment with Sitagliptin, a dipeptidyl peptidase-4 inhibitor, reduces colon carcinogenesis and reactive oxygen species in 1,2-dimethylhydrazine-induced rats","volume":"133","author":"Femia","year":"2013","journal-title":"International Journal of Cancer"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.02.015_bb0380","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1055\/s-0031-1273682","article-title":"Decrease in dipeptidyl peptidase IV activity is linked to the efficacy of differentiating compounds in follicular thyroid carcinoma cell lines","volume":"43","author":"Fr\u00f6hlich","year":"2011","journal-title":"Hormone and Metabolic Research"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.02.015_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115647","article-title":"Clinical significance of soluble CD26 in malignant pleural mesothelioma","volume":"9","author":"Fujimoto","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb0390","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.3892\/ol.2017.6698","article-title":"Sitagliptin, a dipeptidyl peptidase-4 inhibitor, suppresses CXCL5 and SDF-1 and does not accelerate intestinal neoplasia formation in ApcMin\/+ mice fed a high-fat diet","volume":"14","author":"Fujiwara","year":"2017","journal-title":"Oncology Letters"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb0395","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.imbio.2016.09.007","article-title":"Dipeptidyl peptidase 9 (DPP9) in human skin cells","volume":"222","author":"Gabrilovac","year":"2017","journal-title":"Immunobiology"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.02.015_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078378","article-title":"Targeted inactivation of dipeptidyl peptidase 9 enzymatic activity causes mouse neonate lethality","volume":"8","author":"Gall","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb0405","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5301\/JBM.5000020","article-title":"Cytometric profiling of CD133 + cells in human colon carcinoma cell lines identifies a common core phenotype and cell type-specific mosaics","volume":"28","author":"Gemei","year":"2013","journal-title":"The International Journal of Biological Markers"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb0410","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bbrc.2010.12.054","article-title":"Identification of cancer stem cell markers in human malignant mesothelioma cells","volume":"404","author":"Ghani","year":"2011","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb0415","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-3083.2001.00984.x","article-title":"CD26: A multifunctional integral membrane and secreted protein of activated lymphocytes","volume":"54","author":"Gorrell","year":"2001","journal-title":"Scandinavian Journal of Immunology"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2019.02.015_bb0420","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000151741","article-title":"Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus: A study of 229 cases from Anyang tumor Hospital, Henan Province, China","volume":"75","author":"Goscinski","year":"2008","journal-title":"Oncology"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.02.015_bb0425","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1600-0463.2008.01029.x","article-title":"Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal squamous cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines","volume":"116","author":"Goscinski","year":"2008","journal-title":"APMIS (Acta Pathologica, Microbiologica et Immunologica Scandinavica)"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb0430","first-page":"560","article-title":"Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cells","volume":"5","author":"Grunt","year":"2015","journal-title":"American Journal of Cancer Research"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0435","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.regpep.2013.07.003","article-title":"Regulatory Peptides DPP8 and DPP9 expression in cynomolgus monkey and Sprague Dawley rat tissues","volume":"186","author":"Harstad","year":"2013","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0440","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.2741\/2787","article-title":"The role of CD26\/dipeptidyl peptidase IV in cancer","volume":"13","author":"Havre","year":"2008","journal-title":"Frontiers in Bioscience"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb0445","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/sj.bjc.6605236","article-title":"CD26 expression on T cell lines increases SDF-1-\u03b1-mediated invasion","volume":"101","author":"Havre","year":"2009","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-13-517","article-title":"CD26 expression on T-anaplastic large cell Lymphoma (ALCL) line karpas 299 is associated with increased expression of Versican and MT1-MMP and enhanced adhesion","volume":"13","author":"Havre","year":"2013","journal-title":"BMC Cancer"},{"issue":"7626","key":"10.1016\/j.pharmthera.2019.02.015_bb0455","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature19801","article-title":"T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments","volume":"538","author":"Hawkins","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0460","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12935-016-0310-9","article-title":"A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2\/M cell cycle transition","volume":"16","author":"Hayashi","year":"2016","journal-title":"Cancer Cell International"},{"issue":"25","key":"10.1016\/j.pharmthera.2019.02.015_bb0465","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2013-10-536078","article-title":"Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia","volume":"123","author":"Herrmann","year":"2014","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.02.015_bb0470","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/003655201750422675","article-title":"Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease","volume":"36","author":"Hildebrandt","year":"2001","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb0475","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1440-1827.1999.00859.x","article-title":"Dipeptidyl peptidase IV (DPP IV\/CD26) staining predicts distant metastasis of \u201cbenign\u201d thyroid tumor","volume":"49","author":"Hirai","year":"1999","journal-title":"Pathology International"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb0480","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/1110-1067.198650","article-title":"Dipeptidyl peptidase-4 (CD26): a prognostic marker in patients with B-cell chronic lymphocytic leukemia","volume":"41","author":"Hodeib","year":"2016","journal-title":"The Egyptian Journal of Haematology"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb0485","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1101\/gr.161026.113","article-title":"Genomic and transcriptomic plasticity in treatment-naive ovarian cancer","volume":"24","author":"Hoogstraat","year":"2014","journal-title":"Genome Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.02.015_bb0490","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.celrep.2016.05.011","article-title":"An in vivo gain-of-function screen identifies the Williams-Beuren syndrome gene GTF2IRD1 as a Mammary Tumor promoter","volume":"15","author":"Huo","year":"2016","journal-title":"Cell Reports"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb0495","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bcmd.2015.05.010","article-title":"CD49d and CD26 are independent prognostic markers for disease progression in patients with chronic lymphocytic leukemia","volume":"55","author":"Ibrahem","year":"2015","journal-title":"Blood Cells, Molecules, and Diseases"},{"issue":"14","key":"10.1016\/j.pharmthera.2019.02.015_bb0500","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1158\/1078-0432.CCR-07-0110","article-title":"Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors","volume":"13","author":"Inamoto","year":"2007","journal-title":"Clinical Cancer Research"},{"issue":"11 I","key":"10.1016\/j.pharmthera.2019.02.015_bb0505","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1158\/1078-0432.CCR-06-0361","article-title":"Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27kip1enhancement, and disruption of binding","volume":"12","author":"Inamoto","year":"2006","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb0510","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000333642","article-title":"Staining for dipeptidyl aminopeptidase IV activity in nodular thyroid diseases","volume":"40","author":"Iwabuchi","year":"1996","journal-title":"Acta Cytologica"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.02.015_bb0515","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1210\/en.2017-00461","article-title":"Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-\u03baB Activation","volume":"158","author":"Iwaya","year":"2017","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.02.015_bb0520","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10585-015-9736-z","article-title":"Suppression of lung metastases by the CD26\/DPP4 inhibitor Vildagliptin in mice","volume":"32","author":"Jang","year":"2015","journal-title":"Clinical & Experimental Metastasis"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0525","doi-asserted-by":"crossref","first-page":"S362","DOI":"10.1016\/j.jtho.2016.11.404","article-title":"MA04.10 Lung Cancer Growth is Suppressed by CD26\/DPP4-Inhibition via Enhanced NK Cell and Macrophage Recruitment","volume":"12","author":"Jang","year":"2017","journal-title":"Journal of Thoracic Oncology"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.02.015_bb0530","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1155\/2012\/706745","article-title":"Plasma seprase and DPP4 levels as markers of disease and prognosis in cancer","volume":"32","author":"Javidroozi","year":"2012","journal-title":"Disease Markers"},{"issue":"9 Supplement","key":"10.1016\/j.pharmthera.2019.02.015_bb0535","first-page":"1894","article-title":"Abstract 1894: Immune mechanism of action of talabostat: a dipeptidyl peptidase targeted antitumor agent","volume":"67","author":"Jesson","year":"2007","journal-title":"Cancer Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.02.015_bb0540","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/onc.2016.291","article-title":"The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms","volume":"36","author":"Jiang","year":"2017","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.02.015_bb0545","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s41591-018-0082-y","article-title":"DPP8\/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia","volume":"24","author":"Johnson","year":"2018","journal-title":"Nature Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb0550","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1309\/U1Y6-J4AG-5M4M-7AYV","article-title":"Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood","volume":"115","author":"Jones","year":"2001","journal-title":"American Journal of Clinical Pathology"},{"issue":"18","key":"10.1016\/j.pharmthera.2019.02.015_bb0555","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1007\/s00018-014-1591-6","article-title":"The amino terminus extension in the long dipeptidyl peptidase 9 isoform contains a nuclear localization signal targeting the active peptidase to the nucleus","volume":"71","author":"Justa-Schuch","year":"2014","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0560","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.16370","article-title":"DPP9 is a novel component of the N-end rule pathway targeting the tyrosine kinase Syk","volume":"5","author":"Justa-Schuch","year":"2016","journal-title":"ELife"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0565","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12253-011-9412-9","article-title":"Stromal Expression of CD34, \u03b1-Smooth Muscle Actin and CD26\/DPPIV in Squamous Cell Carcinoma of the Skin: A Comparative Immunohistochemical Study","volume":"18","author":"Kacar","year":"2012","journal-title":"Pathology Oncology Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.02.015_bb0570","first-page":"2278","article-title":"Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells","volume":"63","author":"Kajiyama","year":"2003","journal-title":"Cancer Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.02.015_bb0575","first-page":"2753","article-title":"Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma","volume":"62","author":"Kajiyama","year":"2002","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb0580","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1349-7006.2009.01378.x","article-title":"The expression of dipeptidyl peptidase IV (DPPIV\/CD26) is associated with enhanced chemosensitivity to paclitaxel in epithelial ovarian carcinoma cells","volume":"101","author":"Kajiyama","year":"2010","journal-title":"Cancer Science"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.02.015_bb0585","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1080\/10428190600773396","article-title":"CD26, together with cell surface adenosine deaminase, is selectively expressed on ALK-positive, but not on ALK-negative, anaplastic large cell lymphoma and Hodgkin\u2019s lymphoma","volume":"47","author":"Kameoka","year":"2006","journal-title":"Leukemia and Lymphoma"},{"issue":"5120","key":"10.1016\/j.pharmthera.2019.02.015_bb0590","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1126\/science.8101391","article-title":"Direct association of adenosine deaminase with a T cell activation antigen, CD26","volume":"261","author":"Kameoka","year":"1993","journal-title":"Science (New York, N.Y.)"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.02.015_bb0595","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/hepr.12434","article-title":"Synthetic lethal interaction of combined CD26 and Bcl-xL inhibition is a powerful anticancer therapy against hepatocellular carcinoma","volume":"45","author":"Kawaguchi","year":"2015","journal-title":"Hepatology Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb0600","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1365-2249.1998.00513.x","article-title":"Regulation of the expression of aminopeptidase A, aminopeptidase N\/CD13 and dipeptidylpeptidase IV\/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators","volume":"111","author":"Kehlen","year":"1998","journal-title":"Clinical and Experimental Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0605","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1309\/05GFG3LY3VYCDMEY","article-title":"The usefulness of CD26 in flow cytometric analysis of peripheral blood in s\u00e9zary syndrome","volume":"129","author":"Kelemen","year":"2008","journal-title":"American Journal of Clinical Pathology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb0610","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1067\/mob.2003.169","article-title":"Dipeptidyl peptidase IV expression in endometrial endometrioid adenocarcinoma and its inverse correlation with tumor grade","volume":"188","author":"Khin","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0615","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2303.2003.01138.x","article-title":"Dipeptidyl peptidase IV expression in thyroid cytology: Retrospective histologically confirmed study","volume":"14","author":"Kholov\u00e1","year":"2003","journal-title":"Cytopathology"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0620","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbapap.2004.09.028","article-title":"Dipeptidyl peptidase IV in tumor progression","volume":"1751","author":"Kikkawa","year":"2005","journal-title":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb0625","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ydbio.2017.09.001","article-title":"DPP9 enzyme activity controls survival of mouse migratory tongue muscle progenitors and its absence leads to neonatal lethality due to suckling defect","volume":"431","author":"Kim","year":"2017","journal-title":"Developmental Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb0630","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.bbrc.2014.04.037","article-title":"CD26-mediated regulation of periostin expression contributes to migration and invasion of malignant pleural mesothelioma cells","volume":"447","author":"Komiya","year":"2014","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb0635","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0304-3835(91)90158-E","article-title":"Expression of dipeptidyl aminopeptidase IV activity in thyroid carcinoma","volume":"57","author":"Kotani","year":"1991","journal-title":"Cancer Letters"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0640","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.1711680108","article-title":"Diagnostic usefulness of dipeptidyl aminopeptidase IV monoclonal antibody in paraffin-embedded thyroid follicular tumours","volume":"168","author":"Kotani","year":"1992","journal-title":"The Journal of Pathology"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0645","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02713804","article-title":"Dipeptidyl peptidase IV in mammalian lungs","volume":"163","author":"K\u0159epela","year":"1985","journal-title":"Lung"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.02.015_bb0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098582","article-title":"Prognostic significance of CD26 in patients with colorectal cancer","volume":"9","author":"Lam","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb0655","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/713609354","article-title":"Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV","volume":"40","author":"Lambeir","year":"2003","journal-title":"Critical Reviews in Clinical Laboratory Sciences"},{"issue":"32","key":"10.1016\/j.pharmthera.2019.02.015_bb0660","doi-asserted-by":"crossref","first-page":"29839","DOI":"10.1074\/jbc.M103106200","article-title":"Kinetic investigation of chemokine truncation by CD26\/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family","volume":"276","author":"Lambeir","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.02.015_bb0665","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2337\/db10-1707","article-title":"Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome","volume":"60","author":"Lamers","year":"2011","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.pharmthera.2019.02.015_bb0670","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.2337\/diabetes.54.10.2988","article-title":"Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9","volume":"54","author":"Lankas","year":"2005","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.02.015_bb0675","doi-asserted-by":"crossref","first-page":"F1584","DOI":"10.1152\/ajprenal.00477.2012","article-title":"The impact of peptidase activity on clear cell renal cell carcinoma survival","volume":"303","author":"Larrinaga","year":"2012","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.02.015_bb0680","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bjc.6603932","article-title":"Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies","volume":"97","author":"Larsson","year":"2007","journal-title":"British Journal of Cancer"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.02.015_bb0685","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/cyto.a.22095","article-title":"Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes","volume":"81A","author":"Leccia","year":"2012","journal-title":"Cytometry Part A"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.02.015_bb0690","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1210\/jc.2017-00346","article-title":"Dipeptidyl peptidase IV as a prognostic marker and therapeutic target in papillary thyroid carcinoma","volume":"102","author":"Lee","year":"2017","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb0695","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10585-010-9364-6","article-title":"The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells","volume":"28","author":"Lefort","year":"2011","journal-title":"Clinical & Experimental Metastasis"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb0700","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.18632\/oncotarget.13820","article-title":"DPP4\/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness","volume":"8","author":"Liang","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb0705","first-page":"46","article-title":"Metastatic cancer stem cells: from the concept to therapeutics","volume":"3","author":"Liao","year":"2014","journal-title":"American Journal of Stem Cells"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0710","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/bbrc.1995.2782","article-title":"The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site","volume":"217","author":"L\u00f6ster","year":"1995","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"31","key":"10.1016\/j.pharmthera.2019.02.015_bb0715","doi-asserted-by":"crossref","first-page":"27494","DOI":"10.1074\/jbc.M111.224089","article-title":"Dipeptidyl peptidases as survival factors in Ewing sarcoma family of tumors: Implications for tumor biology and therapy","volume":"286","author":"Lu","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"issue":"8","key":"10.1016\/j.pharmthera.2019.02.015_bb0720","first-page":"647","article-title":"Expression of CD26 and CXCR4 in prostate carcinoma and its relationship with clinical parameters","volume":"18","author":"Lu","year":"2013","journal-title":"Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.02.015_bb0725","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1189\/jlb.0906546","article-title":"Dipeptidyl peptidase 8\/9-like activity in human leukocytes","volume":"81","author":"Maes","year":"2007","journal-title":"Journal of Leukocyte Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb0730","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5217\/ir.2017.15.3.352","article-title":"Changes in serum levels of lipopolysaccharides and CD26 in patients with Crohn\u2019s disease","volume":"15","author":"Magro","year":"2017","journal-title":"Intestinal Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.02.015_bb0735","first-page":"931","article-title":"Compartment- and malignance-dependent up-regulation of \u03b3-glutamyltranspeptidase and dipetidylpeptidase-IV activity in human brain gliomas","volume":"27","author":"Mare\u0161","year":"2012","journal-title":"Histology and Histopathology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb0740","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1515\/bc.2011.002","article-title":"Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries","volume":"392","author":"Matheeussen","year":"2011","journal-title":"Biological Chemistry"},{"issue":"3\u20134","key":"10.1016\/j.pharmthera.2019.02.015_bb0745","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cca.2011.10.031","article-title":"Method comparison of dipeptidyl peptidase IV activity assays and their application in biological samples containing reversible inhibitors","volume":"413","author":"Matheeussen","year":"2012","journal-title":"Clinica Chimica Acta"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb0750","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00395-013-0350-4","article-title":"Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis","volume":"108","author":"Matheeussen","year":"2013","journal-title":"Basic Research in Cardiology"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.02.015_bb0755","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.3109\/10428194.2013.782611","article-title":"Dipeptidyl peptidase IV: Serum activity and expression on lymphocytes in different hematological malignancies","volume":"54","author":"Mati\u0107","year":"2013","journal-title":"Leukemia and Lymphoma"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0760","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2172-13-48","article-title":"Serum activity of DPPIV and its expression on lymphocytes in patients with melanoma and in people with vitiligo","volume":"13","author":"Mati\u0107","year":"2012","journal-title":"BMC Immunology"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0765","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.leukres.2016.06.002","article-title":"The prognostic significance of surface dipeptidylpeptidase IV (CD26) expression in B-cell chronic lymphocytic leukemia","volume":"47","author":"Matuszak","year":"2016","journal-title":"Leukemia Research"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0770","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.2741\/2856","article-title":"Dipeptidyl peptidase IV (DPPIV), a candidate tumor suppressor gene in melanomas is silenced by promoter methylation","volume":"13","author":"McGuinness","year":"2008","journal-title":"Frontiers in Bioscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0775","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-0115(99)00089-0","article-title":"Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides","volume":"85","author":"Mentlein","year":"1999","journal-title":"Regulatory Peptides"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0780","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ajpath.2015.09.014","article-title":"Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract: Implications for the Middle East Respiratory Syndrome","volume":"186","author":"Meyerholz","year":"2016","journal-title":"The American Journal of Pathology"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb0785","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/ijc.2910560603","article-title":"Expression of tumour necrosis factor (TNF\u03b1) and its receptors in benign and malignant breast tissue","volume":"56","author":"Miles","year":"1994","journal-title":"International Journal of Cancer"},{"issue":"3\u20136","key":"10.1016\/j.pharmthera.2019.02.015_bb0790","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/BF00570337","article-title":"Histochemistry of proteases in ependyma, choroid plexus and leptomeninges","volume":"88","author":"Mitro","year":"1988","journal-title":"Histochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0795","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-3083.2011.04340.x","article-title":"Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels","volume":"27","author":"Miyagaki","year":"2013","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.02.015_bb0800","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ijc.20183","article-title":"Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26\/dipeptidyl peptidase IV in endometrial adenocarcinoma","volume":"110","author":"Mizokami","year":"2004","journal-title":"International Journal of Cancer"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb0805","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0609.2009.01273.x","article-title":"Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemia","volume":"83","author":"Molica","year":"2009","journal-title":"European Journal of Haematology"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb0810","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.177.4.1135","article-title":"A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase","volume":"177","author":"Morrison","year":"1993","journal-title":"The Journal of Experimental Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0815","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-016-0769-2","article-title":"Evidence of two distinct functionally specialized fibroblast lineages in breast stroma","volume":"18","author":"Morsing","year":"2016","journal-title":"Breast Cancer Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb0820","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1189\/jlb.3MR0915-401R","article-title":"CD26\/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology","volume":"99","author":"Mortier","year":"2016","journal-title":"Journal of Leukocyte Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb0825","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1182\/blood-2005-04-1492","article-title":"Skin homing of S\u00e9zary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26\/dipeptidylpeptidase IV","volume":"107","author":"Narducci","year":"2006","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.02.015_bb0830","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.molmet.2017.09.004","article-title":"KLK5 induces shedding of DPP4 from circulatory Th17 cells in type 2 diabetes","volume":"6","author":"Nargis","year":"2017","journal-title":"Molecular Metabolism"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.02.015_bb0835","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4161\/cbt.6.11.4874","article-title":"Phase II trial of single agent Val-boroPro (talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer","volume":"6","author":"Narra","year":"2007","journal-title":"Cancer Biology & Therapy"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.02.015_bb0840","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1074\/mcp.M114.038836","article-title":"Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer","volume":"13","author":"Nazarian","year":"2014","journal-title":"Molecular & Cellular Proteomics"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.02.015_bb0845","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.3892\/ol.2015.3063","article-title":"Surgically resected human tumors reveal the biological significance of the gastric cancer stem cell markers CD44 and CD26","volume":"9","author":"Nishikawa","year":"2015","journal-title":"Oncology Letters"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0850","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcmgh.2018.08.008","article-title":"Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice","volume":"7","author":"Nishina","year":"2019","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0855","article-title":"Association between glucose-lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy","author":"Noh","year":"2018","journal-title":"International Journal of Cancer"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.02.015_bb0860","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.chembiol.2011.05.009","article-title":"Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer","volume":"18","author":"Nomura","year":"2011","journal-title":"Chemistry and Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0865","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1309\/AJCP1NA3YCHCDEIG","article-title":"Blood flow cytometry in S\u00e9zary syndrome: New insights on prognostic relevance and immunophenotypic changes during follow-up","volume":"143","author":"Novelli","year":"2015","journal-title":"American Journal of Clinical Pathology"},{"issue":"39","key":"10.1016\/j.pharmthera.2019.02.015_bb0870","doi-asserted-by":"crossref","first-page":"14186","DOI":"10.1073\/pnas.0405266101","article-title":"CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1","volume":"101","author":"Ohnuma","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0875","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086671","article-title":"CD9 Negatively Regulates CD26 Expression and Inhibits CD26-Mediated Enhancement of Invasive Potential of Malignant Mesothelioma Cells","volume":"9","author":"Okamoto","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb0880","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bbrc.2018.08.193","article-title":"Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22","volume":"504","author":"Okamoto","year":"2018","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0885","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nchembio.2229","article-title":"DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis","volume":"13","author":"Okondo","year":"2017","journal-title":"Nature Chemical Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2017.12.013","article-title":"Inhibition of Dpp8\/9 activates the Nlrp1b inflammasome","volume":"25","author":"Okondo","year":"2018","journal-title":"Cell Chemical Biology"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2019.02.015_bb0895","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0378-1119(02)01059-4","article-title":"Identification and characterization of human DPP9, a novel homologue of dipeptidyl peptidase IV","volume":"299","author":"Olsen","year":"2002","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb0900","doi-asserted-by":"crossref","first-page":"26399","DOI":"10.1038\/srep26399","article-title":"Rapid and sensitive detection of early esophageal squamous cell carcinoma with fluorescence probe targeting dipeptidylpeptidase IV","volume":"6","author":"Onoyama","year":"2016","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb0905","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/bjc.2014.605","article-title":"Serum sCD26 for colorectal cancer screening in family-risk individuals: Comparison with faecal immunochemical test","volume":"112","author":"Otero-Est\u00e9vez","year":"2015","journal-title":"British Journal of Cancer"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.02.015_bb0910","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3004","article-title":"Risk of dipeptidyl peptidase-4 (DPP-4) inhibitors on site-specific cancer: A systematic review and meta-analysis","volume":"34","author":"Overbeek","year":"2018","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0915","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/exmp.2000.2309","article-title":"Postmitotic differentiation of colon carcinoma caco-2 cells does not prevent reentry in the cell cycle and tumorigenicity","volume":"69","author":"Pandrea","year":"2000","journal-title":"Experimental and Molecular Pathology"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb0920","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.stem.2010.04.001","article-title":"A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer","volume":"6","author":"Pang","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0925","doi-asserted-by":"crossref","first-page":"952019","DOI":"10.1155\/2015\/952019","article-title":"Dipeptidyl peptidase-4 inhibition may stimulate progression of carcinoid tumor","volume":"2015","author":"Pech","year":"2015","journal-title":"Case Reports in Endocrinology"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.02.015_bb0930","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1023\/A:1010930918055","article-title":"Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells","volume":"18","author":"Pethiyagoda","year":"2000","journal-title":"Clinical & Experimental Metastasis"},{"issue":"53","key":"10.1016\/j.pharmthera.2019.02.015_bb0935","doi-asserted-by":"crossref","first-page":"44320","DOI":"10.1074\/jbc.M112.397224","article-title":"A novel SUMO1-specific interacting motif in dipeptidyl peptidase 9 (DPP9) that is important for enzymatic regulation","volume":"287","author":"Pilla","year":"2012","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0940","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/s41598-017-19055-6","article-title":"Dipeptidyl peptidase-4 inhibitors, pancreatic cancer and acute pancreatitis: A meta-analysis with trial sequential analysis","volume":"8","author":"Pinto","year":"2018","journal-title":"Scientific Reports"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2019.02.015_bb0945","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-5793(98)00830-8","article-title":"Processing by CD26\/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha","volume":"432","author":"Proost","year":"1998","journal-title":"FEBS Letters"},{"issue":"32","key":"10.1016\/j.pharmthera.2019.02.015_bb0950","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1038\/s41388-018-0275-3","article-title":"Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics","volume":"37","author":"Pur\u00e9","year":"2018","journal-title":"Oncogene"},{"issue":"7355","key":"10.1016\/j.pharmthera.2019.02.015_bb0955","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb0960","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.canlet.2018.01.064","article-title":"Inhibition of dipeptidyl peptidase IV prevents high fat diet-induced liver cancer angiogenesis by downregulating chemokine ligand 2","volume":"420","author":"Qin","year":"2018","journal-title":"Cancer Letters"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb0965","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062008","article-title":"Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells","volume":"8","author":"Raschke","year":"2013","journal-title":"PLoS One"},{"issue":"13 Supplement","key":"10.1016\/j.pharmthera.2019.02.015_bb0970","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1158\/1538-7445.AM2017-2629","article-title":"Abstract 2629: The synergy between BXCL701, a DPP inhibitor, and immune checkpoint inhibitors discovered using AI and Big Data analytics","volume":"77","author":"Rastelli","year":"2017","journal-title":"Cancer Research"},{"issue":"15 Supplement","key":"10.1016\/j.pharmthera.2019.02.015_bb0975","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.2018.36.15_suppl.3085","article-title":"Abstract 3085: Efficacy and immune modulation by BXCL701 a dipeptidyl peptidase inhibitor, NKTR-214 a CD122-biased immune agonist with PD1 blockade in murine pancreatic tumors","volume":"36","author":"Rastelli","year":"2018","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb0980","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jdiacomp.2017.01.012","article-title":"Association of dipeptidyl peptidase 4 inhibitors with risk of metastases in patients with type 2 diabetes and breast, prostate or digestive system cancer","volume":"31","author":"Rathmann","year":"2017","journal-title":"Journal of Diabetes and its Complications"},{"issue":"21","key":"10.1016\/j.pharmthera.2019.02.015_bb0985","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1016\/j.febslet.2014.08.029","article-title":"Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up-regulated by hypoxia in human adipocytes and smooth muscle cells","volume":"588","author":"R\u00f6hrborn","year":"2014","journal-title":"FEBS Letters"},{"issue":"22","key":"10.1016\/j.pharmthera.2019.02.015_bb0990","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.1158\/0008-5472.CAN-18-0687","article-title":"Downregulation of Dipeptidyl Peptidase 4 Accelerates Progression to Castration-Resistant Prostate Cancer","volume":"78","author":"Russo","year":"2018","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb0995","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s10147-015-0902-8","article-title":"Prognostic relevance of stromal CD26 expression in rectal cancer after chemoradiotherapy","volume":"21","author":"Saigusa","year":"2016","journal-title":"International Journal of Clinical Oncology"},{"issue":"15","key":"10.1016\/j.pharmthera.2019.02.015_bb1000","doi-asserted-by":"crossref","first-page":"6950","DOI":"10.1158\/0008-5472.CAN-05-0647","article-title":"CD26 regulates p38 mitogen-activated protein kinase\u2013dependent phosphorylation of integrin \u03b21, adhesion to extracellular matrix, and tumorigenicity of T-anaplastic large cell lymphoma karpas 299","volume":"65","author":"Sato","year":"2005","journal-title":"Cancer Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb1005","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1515\/BC.2004.067","article-title":"\u201cDipeptidyl peptidase-IV activity and\/or structure homologs\u201d (DASH) in growth-modulated glioma cell lines","volume":"385","author":"\u0160edo","year":"2004","journal-title":"Biological Chemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb1010","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1517\/17530059.2.6.677","article-title":"Dipeptidyl peptidase-IV and related molecules: markers of malignancy?","volume":"2","author":"\u0160edo","year":"2008","journal-title":"Expert Opinion on Medical Diagnostics"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb1015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3233\/CBM-2010-0155","article-title":"Assessment of novel combinations of biomarkers for the detection of colorectal cancer","volume":"7","author":"Shimwell","year":"2010","journal-title":"Cancer Biomarkers"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.02.015_bb1020","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s00262-003-0392-9","article-title":"CD26 expression determines lung metastasis in mutant F344 rats: involvement of NK cell function and soluble CD26","volume":"52","author":"Shingu","year":"2003","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.02.015_bb1025","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1073\/pnas.95.11.6331","article-title":"Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26\/dipeptidyl peptidase IV-mediated cleavage","volume":"95","author":"Shioda","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb1030","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1053\/gast.2000.18142","article-title":"Cdx1 and Cdx2 expression during intestinal development","volume":"119","author":"Silberg","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb1035","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1186\/s12885-017-3625-6","article-title":"Involvement of DPP9 in gene fusions in serous ovarian carcinoma","volume":"17","author":"Smebye","year":"2017","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb1040","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2230.2005.01904.x","article-title":"Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with S\u00e9zary syndrome","volume":"30","author":"Sokolowska-Wojdylo","year":"2005","journal-title":"Clinical and Experimental Dermatology"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb1045","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/leu.2013.9","article-title":"Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide\u2019s anti-leukemic activity","volume":"27","author":"Spagnuolo","year":"2013","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb1050","first-page":"785","article-title":"Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade","volume":"31","author":"Stremenov\u00e1","year":"2007","journal-title":"International Journal of Oncology"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb1055","first-page":"351","article-title":"Expression of dipeptidyl peptidase-IV activity and\/or structure homologs in human meningiomas","volume":"36","author":"Stremenov\u00e1","year":"2010","journal-title":"International Journal of Oncology"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb1060","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4161\/cbt.10.2.12168","article-title":"Expression and prognostic assessment of dipeptidyl peptidase IV and related enzymes in B-cell chronic lymphocytic leukemia","volume":"10","author":"Sulda","year":"2010","journal-title":"Cancer Biology & Therapy"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.02.015_bb1065","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10585-008-9188-9","article-title":"CD26\/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1\/CXCL12","volume":"25","author":"Sun","year":"2008","journal-title":"Clinical and Experimental Metastasis"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb1070","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/jcb.10522","article-title":"Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo","volume":"89","author":"Sun","year":"2003","journal-title":"Journal of Cellular Biochemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.02.015_bb1075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cancergen.2013.04.002","article-title":"Integrative analysis of copy number alteration and gene expression profiling in ovarian clear cell adenocarcinoma","volume":"206","author":"Sung","year":"2013","journal-title":"Cancer Genetics"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb1080","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2017.03.009","article-title":"Pyroptosis and apoptosis pathways engage in bidirectional crosstalk in monocytes and macrophages","volume":"24","author":"Taabazuing","year":"2017","journal-title":"Cell Chemical Biology"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb1085","first-page":"1832","article-title":"Use of the stromal cell-derived factor-1\/CXCR4 pathway in prostate cancer metastasis to bone","volume":"62","author":"Taichman","year":"2002","journal-title":"Cancer Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.02.015_bb1090","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/ijc.30571","article-title":"Contribution of upregulated dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity, metastasis and the prediction of poor prognosis in non-small cell lung cancer (NSCLC)","volume":"140","author":"Tang","year":"2017","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb1095","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/bjc.2012.104","article-title":"Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening","volume":"106","author":"Tao","year":"2012","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb1100","author":"The Human Protein Atlas"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb1105","author":"The Human Protein Atlas"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb1110","author":"The Human Protein Atlas"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb1115","author":"The Human Protein Atlas"},{"issue":"6340","key":"10.1016\/j.pharmthera.2019.02.015_bb1120","doi-asserted-by":"crossref","first-page":"eaal3321","DOI":"10.1126\/science.aal3321","article-title":"A subcellular map of the human proteome","volume":"356","author":"Thul","year":"2017","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.02.015_bb1125","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/cncr.29090","article-title":"Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma - Associations with tumor phenotype and survival","volume":"121","author":"Tilan","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb1130","doi-asserted-by":"crossref","first-page":"10040","DOI":"10.1038\/s41598-017-09929-0","article-title":"Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition","volume":"7","author":"Tiran","year":"2017","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb1135","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA: a Cancer Journal for Clinicians"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.02.015_bb1140","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.metabol.2014.06.004","article-title":"Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetes","volume":"63","author":"Tremblay","year":"2014","journal-title":"Metabolism, Clinical and Experimental"},{"issue":"6220","key":"10.1016\/j.pharmthera.2019.02.015_bb1145","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"issue":"6352","key":"10.1016\/j.pharmthera.2019.02.015_bb1150","doi-asserted-by":"crossref","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.02.015_bb1155","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/eci.12368","article-title":"DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia","volume":"44","author":"Valent","year":"2014","journal-title":"European Journal of Clinical Investigation"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.02.015_bb1160","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"Van Dongen","year":"2012","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb1165","first-page":"30","article-title":"Evaluation of blood parameters for the monitoring of erythrodermic cutaneous T-cell lymphoma","volume":"13","author":"Vandersee","year":"2015","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb1170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cca.2015.07.007","article-title":"Serum dipeptidyl peptidase IV activity and sCD26 concentration in patients with choroidal nevus or uveal melanoma","volume":"448","author":"Varela-Calvi\u00f1o","year":"2015","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb1175","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/1471-2407-10-193","article-title":"Expression and activity profiles of DPP IV\/CD26 and NEP\/CD10 glycoproteins in the human renal cancer are tumor-type dependent","volume":"10","author":"Varona","year":"2010","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb1180","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.semcancer.2006.07.015","article-title":"The Myc oncoprotein as a therapeutic target for human cancer","volume":"16","author":"Vita","year":"2006","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb1185","series-title":"Immunity and Inflammation in Health and Disease (1st ed., pp. 133\u2013147)","article-title":"Chapter 11 - DPPIV\/CD26 as a Target in Anti-inflammatory Therapy","author":"Vliegen","year":"2018"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb1190","doi-asserted-by":"crossref","first-page":"130","DOI":"10.21037\/atm.2017.03.36","article-title":"The expression of proline-specific enzymes in the human lung","volume":"5","author":"Vliegen","year":"2017","journal-title":"Annals of Translational Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb1195","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/10428194.2017.1334123","article-title":"CD4+CD26\u2212lymphocytes are useful to assess blood involvement and define B ratings in cutaneous T cell lymphoma","volume":"59","author":"Vonderheid","year":"2018","journal-title":"Leukemia and Lymphoma"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb1200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4274\/tjh.2016.0502","article-title":"Transformation of mycosis fungoides\/sezary syndrome: Clinical characteristics and prognosis","volume":"35","author":"Vural","year":"2017","journal-title":"Turkish Journal of Hematology"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb1205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058860","article-title":"Val-boroPro accelerates T cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumors","volume":"8","author":"Walsh","year":"2013","journal-title":"PLoS One"},{"issue":"334","key":"10.1016\/j.pharmthera.2019.02.015_bb1210","doi-asserted-by":"crossref","first-page":"334ra51","DOI":"10.1126\/scitranslmed.aad6095","article-title":"NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis","volume":"8","author":"Wang","year":"2016","journal-title":"Science Translational Medicine"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.02.015_bb1215","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1074\/jbc.M707465200","article-title":"The role of CXCR7\/RDC1 as a chemokine receptor for CXCL12\/SDF-1 in prostate cancer","volume":"283","author":"Wang","year":"2008","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb1220","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.peptides.2014.05.006","article-title":"Soluble DPP4 originates in part from bone marrow cells and not from the kidney","volume":"57","author":"Wang","year":"2014","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb1225","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbcan.2010.06.001","article-title":"Targeting Notch signaling pathway to overcome drug resistance for cancer therapy","volume":"1806","author":"Wang","year":"2010","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb1230","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/path.4188","article-title":"Tumour necrosis factor and cancer","volume":"230","author":"Waters","year":"2013","journal-title":"The Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb1235","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fimmu.2015.00387","article-title":"The dipeptidyl peptidase family, prolyl oligopeptidase, and prolyl carboxypeptidase in the immune system and inflammatory disease, including atherosclerosis","volume":"6","author":"Waumans","year":"2015","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2019.02.015_bb1240","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10753-015-0263-5","article-title":"The dipeptidyl peptidases 4, 8, and 9 in mouse monocytes and macrophages: DPP8\/9 inhibition attenuates m1 macrophage activation in mice","volume":"39","author":"Waumans","year":"2016","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb1245","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1084\/jem.190.3.311","article-title":"A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells","volume":"190","author":"Wesley","year":"1999","journal-title":"The Journal of Experimental Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb1250","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1158\/0008-5472.CAN-04-1852","article-title":"Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway","volume":"65","author":"Wesley","year":"2005","journal-title":"Cancer Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2019.02.015_bb1255","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/ijc.20091","article-title":"Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells","volume":"109","author":"Wesley","year":"2004","journal-title":"International Journal of Cancer"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb1260","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3892\/ijo.2012.1522","article-title":"Expression profiling of dipeptidyl peptidase 8 and 9 in breast and ovarian carcinoma cell lines","volume":"41","author":"Wilson","year":"2012","journal-title":"International Journal of Oncology"},{"issue":"20","key":"10.1016\/j.pharmthera.2019.02.015_bb1265","doi-asserted-by":"crossref","first-page":"13936","DOI":"10.1074\/jbc.M112.445841","article-title":"Identifying natural substrates for dipeptidyl peptidases 8 and 9 using terminal amine isotopic labeling of substrates (TAILS) reveals in vivo roles in cellular homeostasis and energy metabolism","volume":"288","author":"Wilson","year":"2013","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb1270","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/01.ju.0000168621.84017.5c","article-title":"Elevation of dipeptidylpeptidase IV activities in the prostate peripheral zone and prostatic secretions of men with prostate cancer: Possible prostate cancer disease marker","volume":"174","author":"Wilson","year":"2005","journal-title":"Journal of Urology"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb1275","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/j.1939-4640.2000.tb02099.x","article-title":"Dipeptidylpeptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands","volume":"21","author":"Wilson","year":"2000","journal-title":"Journal of Andrology"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb1280","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s13402-016-0280-x","article-title":"TNF-\u03b1 promotes breast cancer cell migration and enhances the concentration of membrane-associated proteases in lipid rafts","volume":"39","author":"Wolczyk","year":"2016","journal-title":"Cellular Oncology"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb1285","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.arcmed.2016.07.005","article-title":"Prognostic Significance of Serum CD26 Concentration in Patients with Esophageal Squamous Cell Carcinoma","volume":"47","author":"Xinhua","year":"2016","journal-title":"Archives of Medical Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb1290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062304","article-title":"Nuclear localization of CD26 induced by a humanized monoclonal antibody inhibits tumor cell growth by modulating of POLR2A transcription","volume":"8","author":"Yamada","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.pharmthera.2019.02.015_bb1295","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1038\/bjc.2014.151","article-title":"Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma","volume":"110","author":"Yamamoto","year":"2014","journal-title":"British Journal of Cancer"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.02.015_bb1300","doi-asserted-by":"crossref","first-page":"8679","DOI":"10.18632\/oncotarget.14412","article-title":"DPPIV promotes endometrial carcinoma cell proliferation, invasion and tumorigenesis","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.02.015_bb1305","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1158\/1541-7786.MCR-10-0272","article-title":"A novel role of dipeptidyl peptidase 9 in epidermal growth factor signaling","volume":"9","author":"Yao","year":"2011","journal-title":"Molecular Cancer Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2019.02.015_bb1310","doi-asserted-by":"crossref","first-page":"512","DOI":"10.21037\/tcr.2016.08.38","article-title":"Elevated serum CD26 level is associated with metastasis and post-operation survival in pancreatic cancer patients","volume":"5","author":"Ye","year":"2016","journal-title":"Translational Cancer Research"},{"issue":"12","key":"10.1016\/j.pharmthera.2019.02.015_bb1315","doi-asserted-by":"crossref","first-page":"15677","DOI":"10.1007\/s13277-016-5315-4","article-title":"Suppression of CD26 inhibits growth and metastasis of pancreatic cancer","volume":"37","author":"Ye","year":"2016","journal-title":"Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb1320","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3892\/or.2015.4429","article-title":"The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice","volume":"35","author":"Yorifuji","year":"2016","journal-title":"Oncology Reports"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.02.015_bb1325","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1369\/jhc.2009.953760","article-title":"The In Vivo Expression of Dipeptidyl Peptidases 8 and 9","volume":"57","author":"Yu","year":"2009","journal-title":"Journal of Histochemistry and Cytochemistry"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.02.015_bb1330","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1111\/j.1742-4658.2006.05253.x","article-title":"Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis","volume":"273","author":"Yu","year":"2006","journal-title":"FEBS Journal"},{"issue":"2","key":"10.1016\/j.pharmthera.2019.02.015_bb1335","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.bbamcr.2014.11.029","article-title":"Dipeptidyl peptidase 9 subcellular localization and a role in cell adhesion involving focal adhesion kinase and paxillin","volume":"1853","author":"Zhang","year":"2015","journal-title":"Biochimica et Biophysica Acta"},{"issue":"3","key":"10.1016\/j.pharmthera.2019.02.015_bb1340","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12032-013-0608-6","article-title":"Synergistic relationship between dipeptidyl peptidase IV and neutral endopeptidase expression and the combined prognostic significance in osteosarcoma patients","volume":"30","author":"Zhang","year":"2013","journal-title":"Medical Oncology"},{"issue":"11","key":"10.1016\/j.pharmthera.2019.02.015_bb1345","first-page":"848","article-title":"Correlation of DPPIV expression with clinicopathological features and prognosis in epithelial ovarian carcinoma","volume":"30","author":"Zhang","year":"2008","journal-title":"Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb1350","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3892\/ol.2015.3151","article-title":"Expression levels of seprase\/FAP\u03b1 and DPPIV\/CD26 in epithelial ovarian carcinoma","volume":"10","author":"Zhang","year":"2015","journal-title":"Oncology Letters"},{"issue":"4","key":"10.1016\/j.pharmthera.2019.02.015_bb1355","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jid.2016.01.018","article-title":"The Long Noncoding RNA SPRIGHTLY Regulates Cell Proliferation in Primary Human Melanocytes","volume":"136","author":"Zhao","year":"2016","journal-title":"Journal of Investigative Dermatology"},{"issue":"7","key":"10.1016\/j.pharmthera.2019.02.015_bb1360","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/ijc.29172","article-title":"A three-gene panel that distinguishes benign from malignant thyroid nodules","volume":"136","author":"Zheng","year":"2015","journal-title":"International Journal of Cancer"},{"issue":"49","key":"10.1016\/j.pharmthera.2019.02.015_bb1365","doi-asserted-by":"crossref","first-page":"18864","DOI":"10.1074\/jbc.RA118.004350","article-title":"Human DPP9 represses NLRP1 inflammasome and protects against auto-inflammatory diseases via both peptidase activity and FIIND domain binding","volume":"293","author":"Zhong","year":"2018","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.02.015_bb1370","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fimmu.2015.00477","article-title":"Dipeptidyl Peptidase-4 Regulation of SDF-1\/CXCR4 Axis: Implications for Cardiovascular Disease","volume":"6","author":"Zhong","year":"2015","journal-title":"Frontiers in Immunology"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372581930035X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372581930035X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:55:39Z","timestamp":1759010139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016372581930035X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":274,"alternative-id":["S016372581930035X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2019.02.015","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD26\/DPP4 - a potential biomarker and target for cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2019.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}